Phase 1/2 study of IMC-C103C, a T cell receptor bispecific…
A new T cell-redirecting therapy shows anti-tumor activity across multiple solid cancers with a manageable safety profile, opening possibilities for patients with MAGE-A4-positive tumors.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Safety and efficacy of fecal microbiota transplantation in solid…
Reconstituting gut bacteria from immune responders appears safe and shows early promise for helping immunotherapy-resistant cancer patients respond to treatment.
NONEAI-assisted decision support for sickle cell disease severity…
Simple blood tests combined with AI can help identify sickle cell disease severity in resource-limited settings, enabling earlier intervention and better care planning.
NONEAllogeneic hematopoietic cell transplantation from haploidentical…
Large registry data clarifies trade-offs between two conditioning approaches for blood cell transplants in leukemia, helping doctors choose the right strategy for each patient.
NONEAnti-BNLF2b antibody for accurate diagnosis of nasopharyngeal carcinoma
A new blood test for nasopharyngeal cancer detects the disease as accurately as existing tests, potentially improving screening in high-risk regions.